Bottom line
Is JCMAX a good fund? The bottom line
JCMAX is the Class A share class of JPMorgan Mid Cap Equity Fund, a managed mid-cap mutual fund from J.P. Morgan.
Its expense ratio is 1.04% — about $104 a year on every $10,000 invested, more expensive than 65% of mid-cap funds we track.
It returned +0.2% over one year, +5.8% a year over five years, +9.8% a year over ten (as of Dec 31, 2025, per its prospectus).
With $6.2 billion in net assets and 208 holdings, its largest position is JPMorgan Prime Money Market Fund (2.9%) and the top 10 make up 15.2% of the portfolio.
This share class carries a front-end sales charge of up to 5.25%; a no-load class or ETF alternative can avoid it.
What stands out
- Broadly diversified (208 holdings)
What to watch
- Front-end sales load up to 5.25%
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What JCMAX invests in
The Funds objective is long-term capital growth.
Under normal circumstances, the Fund invests at least 80% of its Assets in equity securities of mid cap companies. Equity securities represent an ownership interest in the issuer. Mid cap companies are companies with market capitalizations equal to those within the universe of the Russell Midcap Index at the time of purchase. As of the reconstitution of the Russell Midcap Index on September 30, 2026, the market capitalizations of the companies in the index ranged from $1.76 billion to $251.61 billion. In implementing its main strategies, the Fund invests primarily in common stocks and real estate investment trusts (REITs). Assets means net assets, plus the amount of borrowings for investment purposes. Derivatives, which are instruments that have a value based on another instrument, exchange rate or index, may be used as substitutes for securities in which the Fund can invest. To the…
From the fund's prospectus (filed Oct 27, 2026).
JCMAX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| JCMAX | +0.2% | +5.8% | +9.8% |
| Mid-Cap median | +7.9% | +8.1% | +9.9% |
Source: Fund prospectus, as of Dec 31, 2025
What JCMAX costs
On a $10,000 investment, JCMAX's 1.04% expense ratio costs about $104 a year. The prospectus estimates $1,890 in total costs over 10 years (assuming 5% annual returns). The median mid-cap fund charges 0.88%.
JCMAX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | JPMorgan Prime Money Market Fund | 2.89% |
| 2 | IQVIA Holdings, Inc. | 1.75% |
| 3 | MKS, Inc. | 1.73% |
| 4 | AMETEK, Inc. | 1.43% |
| 5 | Cencora, Inc. | 1.39% |
| 6 | Jabil, Inc. | 1.37% |
| 7 | Silgan Holdings, Inc. | 1.21% |
| 8 | Healthpeak Properties, Inc. | 1.20% |
| 9 | Fidelity National Information Services, Inc. | 1.12% |
| 10 | Ameriprise Financial, Inc. | 1.11% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 15.2% of the fund. See all top 25 holdings and asset mix →